Antidiabetic Activity of Ruellia tuberosa L., Role of α-Amylase Inhibitor: In Silico, In Vitro, and In Vivo Approaches

Table 2

Effect of HFME on amylase unit activity in vivo.

Groups	Control	Diabetic control	Therapeutic
Amylase unit activity	404,6 ± 5,37	386,6 ± 31,25	228,3 ± 68,70

Values are given as mean ± SD for groups of six animals each. Values are statistically significant .